Damage to hair follicles after exposure to chemotherapeutics
and radiotherapy can cause substantial hair
loss known as chemotherapy-induced alopecia (CIA) and
radiotherapy-induced alo-pecia (RIA). Chemotherapy
induced alopecia has been studied in human beings
and animals since chemotherapy was first introduced
into clinical medicine and is often considered by health
care professionals as a „temporary“ and “cosmetic“
issue in cancer survivors, although this side-effect of
chemotherapy is more complex and can be psychological
overwhelming [2,4,13]. Therapeutic options remain
limited in number and efficacy; additional research is
needed in order to determine optimal preventive and
therapeutic approaches. Scalp cooling technologies have
proved successful in preventing or reducing hair loss in
some patients.